Stonepine Capital Management, LLC has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $158 Billion distributed in 38 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $37.4B, Evolus, Inc. with a value of $22.2B, Galapagos Nv with a value of $13.8B, Jazz Pharmaceuticals PLC with a value of $6.13B, and Royalty Pharma PLC with a value of $6B.
Examining the 13F form we can see an increase of $48.6B in the current position value, from $110B to 158B.
Stonepine Capital Management, LLC is based out at Bend, OR
Below you can find more details about Stonepine Capital Management, LLC portfolio as well as his latest detailed transactions.
